Stay updated on Pembrolizumab and TKI in CML MRD Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.
Screenshot error
Open in browserReport Problem
Clouds background image

Latest updates to the Pembrolizumab and TKI in CML MRD Clinical Trial page

  1. Check
    68 days ago
    Change Detected
    Summary
    The website has updated its contact information for study inquiries, replacing the previous list of principal investigators with a new section titled 'Contacts and Locations' that includes numerous site public contacts.
    Difference
    49%
    Check dated 2025-01-08T07:59:03.000Z thumbnail image
  2. Check
    134 days ago
    Change Detected
    Summary
    The website has been updated from version v2.11.2 to v2.12.1, indicating a new release with potential improvements or features.
    Difference
    0.2%
    Check dated 2024-11-03T22:56:18.000Z thumbnail image
  3. Check
    151 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-10-17T22:56:04.000Z thumbnail image
  4. Check
    158 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-10-10T15:43:33.000Z thumbnail image
  5. Check
    165 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.0%
    Check dated 2024-10-03T07:02:49.000Z thumbnail image
  6. Check
    173 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.
    Difference
    0.4%
    Check dated 2024-09-25T23:36:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and TKI in CML MRD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.